As of 2025-09-16, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is (5.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.97 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -181.2%.
The range of the Relative Valuation is (4.74) - (6.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 12.7x | 9.6x |
| Forward P/E multiples | 8.0x - 11.0x | 9.5x |
| Fair Price | (4.74) - (6.52) | (5.66) |
| Upside | -168.0% - -193.5% | -181.2% |
| Date | P/E |
| 2025-09-11 | -12.08 |
| 2025-09-10 | -12.47 |
| 2025-09-09 | -12.62 |
| 2025-09-08 | -12.79 |
| 2025-09-05 | -13.99 |
| 2025-09-04 | -13.81 |
| 2025-09-03 | -13.50 |
| 2025-09-02 | -16.24 |
| 2025-08-29 | -16.20 |
| 2025-08-28 | -16.76 |
| 2025-08-27 | -17.01 |
| 2025-08-26 | -16.83 |
| 2025-08-25 | -16.78 |
| 2025-08-22 | -17.13 |
| 2025-08-21 | -16.47 |
| 2025-08-20 | -15.95 |
| 2025-08-19 | -16.05 |
| 2025-08-18 | -16.44 |
| 2025-08-15 | -16.47 |
| 2025-08-14 | -15.04 |
| 2025-08-13 | -14.78 |
| 2025-08-12 | -14.26 |
| 2025-08-11 | -13.68 |
| 2025-08-08 | -13.65 |
| 2025-08-07 | -13.72 |
| 2025-08-06 | -14.43 |
| 2025-08-05 | -14.92 |
| 2025-08-04 | -14.77 |
| 2025-08-01 | -14.56 |
| 2025-07-31 | -13.67 |
| 2025-07-30 | -13.77 |
| 2025-07-29 | -14.04 |
| 2025-07-28 | -13.81 |
| 2025-07-25 | -14.18 |
| 2025-07-24 | -14.16 |
| 2025-07-23 | -14.45 |
| 2025-07-22 | -13.38 |
| 2025-07-21 | -13.28 |
| 2025-07-18 | -14.08 |
| 2025-07-17 | -13.52 |
| 2025-07-16 | -13.20 |
| 2025-07-15 | -13.01 |
| 2025-07-14 | -13.23 |
| 2025-07-11 | -13.00 |
| 2025-07-10 | -13.42 |
| 2025-07-09 | -13.00 |
| 2025-07-08 | -11.73 |
| 2025-07-07 | -11.92 |
| 2025-07-03 | -11.73 |
| 2025-07-02 | -11.39 |